Contraceptives Market to 2018 – Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen

Publisher Name :
Date: 9-Nov-2012
No. of pages: 85

GBI Research, a leading business intelligence provider, has released its latest research, “Contraceptives Market to 2018 Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen”, which provides insights into the global contraceptives market and market forecasts until 2018. The report provides an in-depth analysis of the most commonly used contraceptives, such as oral, topical, and injectable contraceptives, and devices such as intrauterine devices, condoms, and vaginal rings. The report also examines the usage patterns and annual cost of usage for these segments. It also includes insights into the contraceptives R&D product pipeline and explores the competitive landscape, including major companies in the contraceptives market. Finally, the report also includes analysis of the mergers and acquisitions (M&A) and licensing agreements that have taken place in the global contraceptives market.

The contraceptives market is growing, and more than 90 million people from seven major markets used them in 2011, with more than 24 million people having used them in the US alone. The user population is expected to grow gradually during the forecast period and reach more than 94 million in 2018.

According to GBI Research’s analysis, in 2011, the contraceptives market was worth $10.2 billion, indicating a Compounded Annual Growth Rate (CAGR) of 2.7% between 2004 and 2011. By 2018, the market is expected to reach $11.8 billion, growing at a CAGR of 2.1%. The launch of the FC patch, AG200-15, Savvy Gel, LNG 20, Pill-Plus and some key products in the late stage pipeline combined with increasing awareness are expected to drive the market.

The annual cost of usage for contraceptives was $113 in 2011, which grew from $104 in 2004 at a CAGR of 1.2%. This is expected to grow to $125 in 2018, at a CAGR of 1.4% between 2011 and 2018. The growth rate can be attributed to factors such as the expected patent expiry of Mirena and Yaz. In the forecast period, CSD500, a condom manufactured by Futura Medical and licensed to Reckitt and Benckiser, is expected to strengthen the condom market.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.

Scope

  • Data and analysis on the contraceptives market in leading geographies: the US, the UK, Germany, France, Italy, Spain and Japan; along with their reach in emerging markets.
  • Annualized market data for oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market from 2004-2011, with forecasts to 2018.
  • Market data on the therapeutic landscape, which covers oral, topical and injectable contraceptives, and includes market revenues, treatment usage patterns and the annual cost of usage.
  • Key drivers and restraints that have had a significant impact on the market.
  • The competitive landscape of the contraceptives market, which includes companies such as Bayer, Merck, Church & Dwight, Warner Chilcott Company, and Pfizer.
  • Key M&A activities and licensing agreements that took place from 2008-2012 in the contraceptives market.

Reasons to buy

  • Align your product portfolio to markets with high growth potential.
  • Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
  • Devise a more specifically-tailored country strategy through understanding of the key drivers and barriers in the contraceptives market of all the major countries.
  • Develop key strategic initiatives by understanding the key focus areas of leading companies.
  • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Contraceptives Market to 2018 – Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen

Table of Contents

1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 9

2 Contraceptives Market to 2018 - Introduction 10

3 Contraceptives Market to 2018 - Market Overview 12
3.1 Introduction 12
3.2 Revenue Forecasts for Contraceptives Market 12
3.2.1 Revenues 12
3.2.2 Annual Cost of Usage for Contraceptives 15
3.2.3 Contraceptive Users 16
3.3 Drivers and Barriers for the Contraceptives Market 17
3.3.1 Drivers for Contraceptives Therapeutics Market 17
3.3.2 Barriers for Contraceptives 18

4 Contraceptives Market to 2018 - Geographical Landscape 19
4.1 The US 19
4.1.1 Revenue 19
4.1.2 Annual Cost of Usage for Contraceptives 20
4.1.3 Contraceptive Users 21
4.2 Top Five Countries of Europe 22
4.2.1 Revenue 22
4.2.2 Annual Cost of Usage for Contraceptives 23
4.2.3 Contraceptive Users 24
4.3 Japan 25
4.3.1 Revenue 25
4.3.2 Annual Cost of Usage for Contraceptives 26
4.3.3 Contraceptive Users 27

5 Contraceptives Market to 2018 - Therapeutic Landscape 28
5.1 Oral Contraceptives 28
5.1.1 Introduction 28
5.1.2 Combined Hormonal Contraception 29
5.1.3 Oral Contraceptive Historic Trends 29
5.1.4 Recently Approved Combined Oral Contraceptives 29
5.1.5 Revenue 30
5.1.6 Annual Cost of Usage 33
5.1.7 Oral Contraceptive Users 34
5.2 Injectables 35
5.2.1 Introduction 35
5.2.2 Revenue 35
5.2.3 Annual Cost of Usage 39
5.2.4 Injectable Contraceptive Users 40
5.3 Topical Contraceptives 41
5.3.1 Introduction 41
5.3.2 Revenue 42
5.3.3 Annual Cost of Usage 45
5.3.4 Topical Contraceptive Users 46

6 Contraceptives Market to 2018 - Devices Landscape 47
6.1 Vaginal Ring 47
6.1.1 Introduction 47
6.1.2 Revenue 47
6.1.3 Geographical Segmentation 49
6.1.4 Annual Cost of Usage 51
6.1.5 Vaginal Ring Users 52
6.2 Intrauterine Device 53
6.2.1 Introduction 53
6.2.2 Revenue 53
6.2.3 Geographical Segmentation 55
6.2.4 Annual Cost of Usage 57
6.2.5 IUDs Users 58
6.3 Condoms 59
6.3.1 Introduction 59
6.3.2 Revenue 59
6.3.3 Geographical Segmentation 60
6.3.4 Annual Cost of Usage 62
6.3.5 Condom Users 63

7 Emerging Markets 64
7.1 China 64
7.2 Australia 65
7.3 India 66

8 Contraceptives Market to 2018 - Pipeline Analysis 67
8.1 Introduction 67
8.2 Profiles of Promising Drugs in the Global Contraceptives Market 68
8.2.1 AG200-15 68
8.2.2 FC Patch Low 68
8.2.3 Pill-Plus 69

9 Contraceptives Market to 2018 - Competitive Landscape 70
9.1 Market Share Analysis - Contraceptives Market 70
9.2 Drug Profile of Major Marketed Contraceptives 71
9.2.1 Yaz/Yasmin 71
9.2.2 Mirena 71
9.2.3 Nuvaring 71
9.3 Competitive Profiling 72
9.3.1 Bayer 72
9.3.2 Merck 73
9.3.3 Church & Dwight 74
9.3.4 Warner Chilcott Company, Inc. 75
9.3.5 Pfizer Inc. 76

10 Contraceptives Market to 2018 - Strategic Consolidations 77
10.1 Mergers and Acquisitions 77
10.1.1 Major M&A Deals 77
10.1.2 Licensing Agreements 77
10.1.3 Deals by Geography 78
10.1.4 Major Licensing Agreements 78
10.1.5 Co-development 79

11 Contraceptives Market to 2018 - Appendix 80
11.1 Market Definitions 80
11.2 Abbreviations 80
11.3 Bibliography 80
11.4 Research Methodology 81
11.4.1 Coverage 82
11.4.2 Secondary Research 82
11.4.3 Primary Research 82
11.4.4 Expert Panel Validation 83
11.5 Therapeutic Landscape 83
11.5.1 Epidemiology-Based Forecasting 83
11.5.2 Market Size by Geography 84
11.6 Geographical Landscape 84
11.7 Pipeline Analysis 84
11.8 Competitive Landscape 84
11.9 Contact Us 85
11.10 Disclaimer 85

List of Tables

Table 1: Contraceptives Market, Global, Revenue ($bn), 2004-2011 12
Table 2: Contraceptives Market, Global, Revenue Forecasts ($bn), 2011-2018 12
Table 3: Contraceptives Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 13
Table 4: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 14
Table 5: Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2011 15
Table 6: Contraceptives Market, Global, Annual Cost of Usage ($), 2011-2018 15
Table 7: Contraceptives Market, Global, Contraceptive Users (Million), 2004-2011 16
Table 8: Contraceptives Market, Global, Contraceptive Users (Million), 2011-2018 16
Table 9: Contraceptives Market, The US, Revenue ($bn), 2004-2011 19
Table 10: Contraceptives Market, The US, Revenue Forecasts ($bn), 2011-2018 19
Table 11: Contraceptives Market, The US, Annual Cost of Usage ($), 2004-2011 20
Table 12: Contraceptives Market, The US, Annual Cost of Usage ($), 2011-2018 20
Table 13: Contraceptives Market, The US, Contraceptive Users (Million), 2004-2011 21
Table 14: Contraceptives Market, The US, Contraceptive Users (Million), 2011-2018 21
Table 15: Contraceptives Market, Top Five Countries of Europe, Revenue ($m), 2004-2011 22
Table 16: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts ($m), 2011-2018 22
Table 17: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage ($), 2004-2011 23
Table 18: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage ($), 2011-2018 23
Table 19: Contraceptives Market, Top Five Countries of Europe, Contraceptive Users (Million), 2004-2011 24
Table 20: Contraceptives Market, Top Five Countries of Europe, Contraceptive Users (Million), 2011-2018 24
Table 21: Contraceptives Market, Japan, Revenue ($m), 2004-2011 25
Table 22: Contraceptives Market, Japan, Revenue Forecasts ($m), 2011-2018 25
Table 23: Contraceptives Market, Japan, Annual Cost of Usage ($), 2004-2011 26
Table 24: Contraceptives Market, Japan, Annual Cost of Usage ($), 2011-2018 26
Table 25: Contraceptives Market, Japan, Contraceptive Users (Million), 2004-2011 27
Table 26: Contraceptives Market, Japan, Contraceptive Users (Million), 2011-2018 27
Table 27: Oral Contraceptives Market, Global, Revenue ($bn), 2004-2011 30
Table 28: Oral Contraceptives Market, Global, Revenue Forecasts ($bn), 2011-2018 30
Table 29: Oral Contraceptives Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 31
Table 30: Oral Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 32
Table 31: Oral Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2011 33
Table 32: Oral Contraceptives Market, Global, Annual Cost of Usage ($), 2011-2018 33
Table 33: Oral Contraceptives Market, Global, Users (Million), 2004-2011 34
Table 34: Oral Contraceptives Market, Global, Users (Million), 2011-2018 34
Table 35: Injectables Market, Global, Revenue ($m), 2004-2011 36
Table 36: Injectables Market, Global, Revenue Forecasts ($m), 2011-2018 36
Table 37: Injectables Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 37
Table 38: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 38
Table 39: Injectables Market, Global, Annual Cost of Usage ($), 2004-2011 39
Table 40: Injectables Market, Global, Annual Cost of Usage ($), 2011-2018 39
Table 41: Injectable Contraceptives Market, Global, Users (‘000), 2004-2011 40
Table 42: Injectable Contraceptives Market, Global, Users (‘000), 2011-2018 40
Table 43: Topical Contraceptives Market, Global, Revenue ($m), 2004-2011 42
Table 44: Topical Contraceptives Market, Global, Revenue Forecasts ($m), 2011-2018 42
Table 45: Topical Contraceptives Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 43
Table 46: Topical Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 44
Table 47: Topical Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2011 45
Table 48: Topical Contraceptives Market, Global, Annual Cost of Usage ($), 2011-2018 45
Table 49: Topical Contraceptives Market, Global, Users (Million), 2004-2011 46
Table 50: Topical Contraceptives Market, Global, Users (Million), 2011-2018 46
Table 51: Vaginal Ring Market, Global, Revenue ($m), 2004-2011 48
Table 52: Vaginal Ring Market, Global, Revenue Forecasts ($m), 2011-2018 48
Table 53: Vaginal Ring Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 49
Table 54: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 50
Table 55: Vaginal Ring Market, Global, Annual Cost of Usage ($), 2004-2011 51
Table 56: Vaginal Ring Market, Global, Annual Cost of Usage ($), 2011-2018 51
Table 57: Vaginal Ring Market, Global, Users ('000), 2004-2011 52
Table 58: Vaginal Ring Market, Global, Users (‘000), 2011-2018 52
Table 59: Intrauterine Devices Market, Global, Revenue ($m), 2004-2011 54
Table 60: Intrauterine Device Market, Global, Revenue Forecasts ($m), 2011-2018 54
Table 61: IUDs Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 55
Table 62: IUDs Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 56
Table 63: IUDs Market, Global, Annual Cost of Usage ($), 2004-2011 57
Table 64: IUDs Market, Global, Annual Cost of Usage ($), 2011-2018 57
Table 65: IUDs Market, Global, Users (Million), 2004-2011 58
Table 66: IUDs Market, Global, Users (Million), 2011-2018 58
Table 67: Condoms Market, Global, Revenue ($bn), 2004-2011 59
Table 68: Condoms Market, Global, Revenue Forecasts ($bn), 2011-2018 59
Table 69: Condoms Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 60
Table 70: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 61
Table 71: Condoms Market, Global, Annual Cost of Usage ($), 2004-2011 62
Table 72: Condoms Market, Global, Annual Cost of Usage ($), 2011-2018 62
Table 73: Condom Market, Global, Users (Million), 2004-2011 63
Table 74: Condom Market, Global, Users (Million), 2011-2018 63
Table 75: Contraceptives Market, Method of Contraceptive Used (%), China 64
Table 76: Contraceptives Market, Method of Contraceptive Used (%), Australia 65
Table 77: Contraceptives Market, Method of Contraceptive Usage (%), India 66
Table 78: Contraceptives Market, Global, Product Pipeline by Phase, 2012 67
Table 79: Contraceptives Market, Global, Revenues of Major Marketed Contraceptives ($m), 2011 71

List of Figures

Figure 1: Contraceptives Market, Global, Revenue Forecasts ($bn), 2004-2018 12
Figure 2: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 13
Figure 3: Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2018 15
Figure 4: Contraceptives Market, Global, Contraceptive Users (Million), 2004-2018 16
Figure 5: Contraceptives Market, Global, Drivers and Barriers, 2011 17
Figure 6: Contraceptives Market, The US, Revenue Forecasts ($bn), 2004-2018 19
Figure 7: Contraceptives Market, The US, Annual Cost of Usage ($), 2004-2018 20
Figure 8: Contraceptives Market, The US, Contraceptive Users (Million), 2004-2018 21
Figure 9: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts ($m), 2004-2018 22
Figure 10: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage ($), 2004-2018 23
Figure 11: Contraceptives Market, Top Five Countries of Europe, Contraceptive Users (Million), 2004-2018 24
Figure 12: Contraceptives Market, Japan, Revenue Forecasts ($m), 2004-2018 25
Figure 13: Contraceptives Market, Japan, Annual Cost of Usage ($), 2004-2018 26
Figure 14: Contraceptives Market, Japan, Contraceptive Users (Million), 2004-2018 27
Figure 15: Oral Contraceptives Market, Global, Revenue Forecasts ($bn), 2004-2018 30
Figure 16: Oral Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 31
Figure 17: Oral Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2018 33
Figure 18: Oral Contraceptives Market, Global, Users (Million), 2004-2018 34
Figure 19: Injectables Market, Global, Revenue Forecasts ($m), 2004-2018 35
Figure 20: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 37
Figure 21: Injectables Market, Global, Annual Cost of Usage ($), 2004-2018 39
Figure 22: Injectable Contraceptives Market, Global, Users (‘000), 2004-2018 40
Figure 23: Topical Contraceptives Market, Global, Revenue Forecasts ($m), 2004-2018 42
Figure 24: Topical Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 43
Figure 25: Topical Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2018 45
Figure 26: Topical Contraceptives Market, Global, Users (Million), 2004-2018 46
Figure 27: Vaginal Ring Market, Global, Revenue Forecasts ($m), 2004-2018 47
Figure 28: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 49
Figure 29: Vaginal Ring Market, Global, Annual Cost of Usage ($), 2004-2018 51
Figure 30: Vaginal Ring Market, Global, Users (‘000), 2004-2018 52
Figure 31: Intrauterine Devices Market, Global, Revenue Forecasts ($m), 2004-2018 53
Figure 32: IUDs Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 55
Figure 33: IUDs Market, Global, Annual Cost of Usage ($), 2004-2018 57
Figure 34: IUDs Market, Global, Users (Million), 2004-2018 58
Figure 35: Condoms Market, Global, Revenue Forecasts ($bn), 2004-2018 59
Figure 36: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 60
Figure 37: Condoms Market, Global, Annual Cost of Usage ($), 2004-2018 62
Figure 38: Condom Market, Global, Users (Million), 2004-2018 63
Figure 39: Contraceptives Market, Global, Product Pipeline by Phase, (%), 2011 67
Figure 40: Contraceptives Market, Global, Market Share Analysis, (%), 2011 70
Figure 41: Contraceptives Market, Global, Bayer, SWOT Analysis, 2011 72
Figure 42: Contraceptives Market, Global, Merck, SWOT Analysis, 2011 73
Figure 43: Contraceptives Market, Global, Church & Dwight, SWOT Analysis, 2011 74
Figure 44: Contraceptives Market, Global, Warner Chilcott Company, Inc., SWOT Analysis, 2011 75
Figure 45: Contraceptives Market, Global, Pfizer Inc., SWOT Analysis, 2011 76
Figure 46: Contraceptives Market, Global, Licensing Agreements by Geography, 2011 78

  • Global Cystic Fibrosis Market Propelled by Technological Advancement
    With increasing prevalence of cystic fibrosis and its growing awareness among people, the global market for cystic fibrosis is expected to grow at a steady pace. Cystic fibrosis is a genetic condition where the lungs and digestive system becomes clogged with excess mucus. This condition is more common among Caucasian population than people of Asian [...]
  • Bright Prospects Ahead for the SONAR Systems and Technology Market
    With advancement of technology, the global SONAR systems and technology market is increasing at a rapid pace. SONAR which is an acronym for SOund Navigation And Ranging is a technique that uses sound propagation to navigate and communicate with objects on or under the surface of the water, such as other vessels. In 2014, the [...]
  • Increase in Surgical Procedures Propelling the Anesthesia Drugs Market
    With increase in surgical operations and invasive medical tests, the market for anesthesia drugs has been growing at a steady pace. Anesthesia drugs can be broadly categorized into two types – general anesthesia drugs and local anesthesia drugs. Anesthetic drugs help in inducing sleep and preventing discomfort and pain during surgical procedures. By 2018, the [...]
  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • To bring in Photography to the Real World Visual Supply Co Acquires Artifact Uprising
  • Visual Supply Co, VSCO has brought a Denver-based startup, Artifact Uprising, which is focused on bringing photographers’ work from the digital hubs on regular basis by modern creatives to the real world as prints and tangible books. Artifact Uprising is …

  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Healthcare IT Market in Africa 2015-2019
    Published: 25-Feb-2015        Price: US $2500 Onwards        Pages: 72
    Healthcare IT refers to the use of IT services, products, software, and solutions by healthcare organizations to integrate and streamline various processes. In healthcare, IT is primarily used to develop a secure environment and maintain a uniform flow of information. It improves the quality and efficiency of the services delivered and helps in reducing errors in the Healthcare industry. The rising number of healthcare institutions and the emerging need to modernize the same is proliferating the......
  • Canada Pharmaceuticals and Healthcare Report Q2 2015
    Published: 25-Feb-2015        Price: US $1295 Onwards        Pages: 101
    BMI View: Supported by strong democratic institutions and a long history of stable political Leadership, Canada is home to the second largest pharmaceutical market in the Americas and one of the largest in world. We believe that drugmakers will continue to realise considerable rewards, as sales of patented pharmaceuticals settle into a trend of steady growth, which is only nominally affected by the particularly slow penetration of generics. However, drugmakers will find their interests threatene......
  • France Pharmaceuticals and Healthcare Report Q2 2015
    Published: 25-Feb-2015        Price: US $1295 Onwards        Pages: 132
    BMI View: France will remain among the largest pharmaceutical markets worldwide in the coming years, especially due to a large and aging population, as well as high per capita spending levels on medicines. However, several cost-containment measures will continue to exert downward pressure on market growth over a multi-year horizon. On the upside, current macroeconomic trends, including low oil and food prices, should be net positive for household consumption in France, posing upside risks to mar......
  • Lebanon Pharmaceuticals and Healthcare Report Q2 2015
    Published: 25-Feb-2015        Price: US $1295 Onwards        Pages: 114
    BMI View: Lebanon's healthcare system is under enormous strain as the number of Syrian refugees seeking treatment in the country has sharply risen. Continued political instability will negatively impact government policy regarding healthcare and will in turn put the pharmaceutical sector at risk. However, high per capita spending, an increasing burden of non-communicable diseases along with efforts by the Health Ministry to tackle high levels of corruption within the sector will help sustain mar......
  • Myanmar Pharmaceuticals and Healthcare Report Q2 2015
    Published: 25-Feb-2015        Price: US $1295 Onwards        Pages: 65
    BMI View: New investment reforms lifting restrictions on the foreign funding of medicine production will make Myanmar an attractive market to international generic drugmakers. This is due to the opportunity of securing a first-mover advantage in this frontier market, as well as being a result of rising medicine consumption. Nonetheless, we highlight that there is significant political uncertainty in Myanmar with the upcoming 2015 elections which poses as a risk to investment. Headline Expenditur......
  • Romania Pharmaceuticals and Healthcare Report Q2 2015
    Published: 25-Feb-2015        Price: US $1295 Onwards        Pages: 110
    BMI View: We expect Romania's pharmaceutical market in 2015 to be initially driven by a consumer-led recovery as falling fuel and food prices, rising wages and declining unemployment drive pharmaceutical consumption, but local regulatory factors such as revenue taxes will continue to present obstacles to growth. Over the longer term, we expect the underfunding of the healthcare system to be addressed and given the country's ageing population, a broad based boost in expenditure from both public p......
  • Slovenia Pharmaceuticals and Healthcare Report Q2 2015
    Published: 25-Feb-2015        Price: US $1295 Onwards        Pages: 94
    BMI View: Our updated forecasts for Slovenia's pharmaceutical and healthcare expenditure indicate a rebound this year from a decline trend that was seen over the past three years. Admittedly, this is true in local currency terms, while the value in USD is expected to take a significant hit, especially in pharmaceutical sales. Headline Expenditure Projections ? Pharmaceuticals: EUR704mn (USD943mn) in 2014 to EUR714mn (USD893mn) in 2015; 1.5% in local currency terms and -5.4% in US dollar terms. F......
  • Healthcare IT Market in India 2015-2019
    Published: 25-Feb-2015        Price: US $2500 Onwards        Pages: 84
    Healthcare IT refers to the use of IT services, products, software, and solutions by healthcare organizations to integrate and streamline various processes. In healthcare, IT is used to develop a secure environment and maintain a uniform flow of information. It improves the quality and efficiency of the services delivered and helps in reducing errors in the Healthcare industry. The rising number of healthcare institutions and the emerging need to modernize the same is contributing to the growth ......
  • 2015 Deep Research Report on Global IVIG Industry
    Published: 23-Feb-2015        Price: US $3600 Onwards        Pages: 163
    This is a professional and depth research report on Global IVIG industry For overview analysis, the report introduces IVIG basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc For international and China market analysis, the report analyzes IVIG markets in China and other countries or regions (such as US, Europe, Japan, etc) by presenting research on global products of different types and a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs